BR9808305A - Forma hidratada cristalina, processo para a preparação da forma hidratada cristalina, composição farmacêutica, processo de tratamento de um mamìfero, e, processo de tratamento ou de prevenção de dor. - Google Patents
Forma hidratada cristalina, processo para a preparação da forma hidratada cristalina, composição farmacêutica, processo de tratamento de um mamìfero, e, processo de tratamento ou de prevenção de dor.Info
- Publication number
- BR9808305A BR9808305A BR9808305-8A BR9808305A BR9808305A BR 9808305 A BR9808305 A BR 9808305A BR 9808305 A BR9808305 A BR 9808305A BR 9808305 A BR9808305 A BR 9808305A
- Authority
- BR
- Brazil
- Prior art keywords
- treating
- hydrated
- crystalline
- preparation
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9704498.6A GB9704498D0 (en) | 1997-03-05 | 1997-03-05 | Chemical compound |
| PCT/EP1998/001146 WO1998039327A1 (en) | 1997-03-05 | 1998-03-03 | Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9808305A true BR9808305A (pt) | 2000-05-16 |
Family
ID=10808697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9808305-8A BR9808305A (pt) | 1997-03-05 | 1998-03-03 | Forma hidratada cristalina, processo para a preparação da forma hidratada cristalina, composição farmacêutica, processo de tratamento de um mamìfero, e, processo de tratamento ou de prevenção de dor. |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0966463A1 (sh) |
| JP (1) | JP2001513796A (sh) |
| KR (1) | KR20000075907A (sh) |
| CN (1) | CN1249750A (sh) |
| AP (1) | AP9901637A0 (sh) |
| AR (1) | AR011178A1 (sh) |
| AU (1) | AU6825198A (sh) |
| BG (1) | BG103779A (sh) |
| BR (1) | BR9808305A (sh) |
| CA (1) | CA2282851A1 (sh) |
| CO (1) | CO4940415A1 (sh) |
| EA (1) | EA199900710A1 (sh) |
| EE (1) | EE9900387A (sh) |
| GB (1) | GB9704498D0 (sh) |
| HR (1) | HRP980114A2 (sh) |
| HU (1) | HUP0002109A2 (sh) |
| ID (1) | ID24207A (sh) |
| IL (1) | IL131489A0 (sh) |
| IS (1) | IS5166A (sh) |
| NO (1) | NO994303L (sh) |
| NZ (1) | NZ337315A (sh) |
| OA (1) | OA11154A (sh) |
| PE (1) | PE51399A1 (sh) |
| PL (1) | PL335652A1 (sh) |
| SK (1) | SK119699A3 (sh) |
| TR (1) | TR199902117T2 (sh) |
| WO (1) | WO1998039327A1 (sh) |
| YU (1) | YU43499A (sh) |
| ZA (1) | ZA981791B (sh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9704499D0 (en) * | 1997-03-05 | 1997-04-23 | Glaxo Wellcome Spa | Method of manufacture |
| GB9825988D0 (en) | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
| GB9915231D0 (en) | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| RU2020100230A (ru) | 2017-06-12 | 2021-07-13 | Глитек Ллс. | Лечение депрессии антагонистами nmda и антагонистами d2/5-ht2a или селективными антагонистами 5-нт2a |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9321221D0 (en) * | 1993-10-14 | 1993-12-01 | Glaxo Spa | Heterocyclic compounds |
-
1997
- 1997-03-05 GB GBGB9704498.6A patent/GB9704498D0/en active Pending
-
1998
- 1998-03-03 PE PE1998000149A patent/PE51399A1/es not_active Application Discontinuation
- 1998-03-03 NZ NZ337315A patent/NZ337315A/en unknown
- 1998-03-03 KR KR1019997007987A patent/KR20000075907A/ko not_active Application Discontinuation
- 1998-03-03 TR TR1999/02117T patent/TR199902117T2/xx unknown
- 1998-03-03 CN CN98803053A patent/CN1249750A/zh active Pending
- 1998-03-03 AR ARP980100948A patent/AR011178A1/es unknown
- 1998-03-03 CO CO98011404A patent/CO4940415A1/es unknown
- 1998-03-03 EA EA199900710A patent/EA199900710A1/ru unknown
- 1998-03-03 BR BR9808305-8A patent/BR9808305A/pt not_active Application Discontinuation
- 1998-03-03 SK SK1196-99A patent/SK119699A3/sk unknown
- 1998-03-03 AU AU68251/98A patent/AU6825198A/en not_active Abandoned
- 1998-03-03 WO PCT/EP1998/001146 patent/WO1998039327A1/en not_active Application Discontinuation
- 1998-03-03 ID IDW990976A patent/ID24207A/id unknown
- 1998-03-03 CA CA002282851A patent/CA2282851A1/en not_active Abandoned
- 1998-03-03 JP JP53813598A patent/JP2001513796A/ja active Pending
- 1998-03-03 IL IL13148998A patent/IL131489A0/xx unknown
- 1998-03-03 PL PL98335652A patent/PL335652A1/xx unknown
- 1998-03-03 YU YU43499A patent/YU43499A/sh unknown
- 1998-03-03 EE EEP199900387A patent/EE9900387A/xx unknown
- 1998-03-03 ZA ZA9801791A patent/ZA981791B/xx unknown
- 1998-03-03 AP APAP/P/1999/001637A patent/AP9901637A0/en unknown
- 1998-03-03 EP EP98913613A patent/EP0966463A1/en not_active Withdrawn
- 1998-03-03 HU HU0002109A patent/HUP0002109A2/hu unknown
- 1998-03-04 HR HR9704498.6A patent/HRP980114A2/hr not_active Application Discontinuation
-
1999
- 1999-08-27 IS IS5166A patent/IS5166A/is unknown
- 1999-09-02 OA OA9900201A patent/OA11154A/fr unknown
- 1999-09-03 NO NO994303A patent/NO994303L/no not_active Application Discontinuation
- 1999-10-04 BG BG103779A patent/BG103779A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1249750A (zh) | 2000-04-05 |
| BG103779A (en) | 2000-06-30 |
| WO1998039327A1 (en) | 1998-09-11 |
| HRP980114A2 (en) | 1998-12-31 |
| YU43499A (sh) | 2000-12-28 |
| ID24207A (id) | 2000-07-13 |
| TR199902117T2 (xx) | 2000-03-21 |
| NZ337315A (en) | 2001-02-23 |
| OA11154A (en) | 2003-04-16 |
| AP9901637A0 (en) | 1999-09-30 |
| AR011178A1 (es) | 2000-08-02 |
| EE9900387A (et) | 2000-04-17 |
| IS5166A (is) | 1999-08-27 |
| SK119699A3 (en) | 2000-05-16 |
| CA2282851A1 (en) | 1998-09-11 |
| CO4940415A1 (es) | 2000-07-24 |
| JP2001513796A (ja) | 2001-09-04 |
| NO994303L (no) | 1999-11-03 |
| PL335652A1 (en) | 2000-05-08 |
| NO994303D0 (no) | 1999-09-03 |
| IL131489A0 (en) | 2001-01-28 |
| EP0966463A1 (en) | 1999-12-29 |
| EA199900710A1 (ru) | 2000-04-24 |
| AU6825198A (en) | 1998-09-22 |
| KR20000075907A (ko) | 2000-12-26 |
| GB9704498D0 (en) | 1997-04-23 |
| HUP0002109A2 (hu) | 2001-04-28 |
| PE51399A1 (es) | 1999-06-07 |
| ZA981791B (en) | 1999-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO308794B1 (no) | Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse | |
| TR199801180T2 (xx) | Aneljestik etkiye sahip yeni bile�ikler. | |
| CA2289717A1 (en) | Novel therapy for constipation | |
| MY123354A (en) | 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives | |
| BR9813373A (pt) | Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente | |
| BR9814375A (pt) | Inibição de raf cinase usando difenil uréias substituìdas simétricas e assimétricas | |
| BR9406363A (pt) | Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico | |
| RU94041223A (ru) | Средство для лечения мотонейроновых заболеваний | |
| BG101118A (en) | Therapeutical compounds | |
| BR0014384A (pt) | Compostos para o tratamento da isquémia | |
| FI964772A0 (fi) | (a)-annelloidut pyrrolijohdannaiset ja niiden käyttö farmasiassa | |
| BR9714677A (pt) | "enantiÈmeros 3-piridila e seu uso como analgésicos" | |
| MY119375A (en) | Treatment of tinnitus using neuroprotective agents | |
| RU94020410A (ru) | Способ лечения или профилактики рвоты у млекопитающих и человека с использованием некоторых хинуклидиновых, пиперидиновых, азанорборнановых, этилендиаминовых производных и родственных им соединений | |
| UA41355C2 (uk) | Засіб для лікування нейро-сніду | |
| BR9813319A (pt) | Composto, composição farmacêutica para tratamento de infecções bacterianas, e, processos para tratar infecções bacterianas e para preparar um composto | |
| WO1992019617A3 (en) | Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use | |
| PT1173201E (pt) | Metodo para o tratamento de fibrose utilizando um antagonista da subunidade alfa 4 de integrina | |
| BR9607346A (pt) | Composto utilizaç o de um composto composiç o farmacéutica e processo para o tratamento de um mamifero e para e preparaç o de compostos | |
| BR9813317A (pt) | Composto, composição farmacêutica para tratar infecções bacterianas, e, processos para tratar infecções bacterianas, e para preparar um composto | |
| BR9814498A (pt) | Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica | |
| BR9808305A (pt) | Forma hidratada cristalina, processo para a preparação da forma hidratada cristalina, composição farmacêutica, processo de tratamento de um mamìfero, e, processo de tratamento ou de prevenção de dor. | |
| BR9708864A (pt) | Composto composição farmacêutica e processo para o tratamento ou a prevenção de uma infecção bacteriana em um paciente mamífero | |
| PT986393E (pt) | Utilizacao de um nitroxido ou de um seu pro-farmaco no tratamento profilactico e terapeutico do cancro | |
| BR9916043A (pt) | Composto, uso do mesmo e de seus saisfarmaceuticamente aceitáveis, e, composiçãofarmacêutica para tratamento de infecções deherpes viral em pacientes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |